(19)
(11) EP 2 076 242 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.02.2013 Bulletin 2013/08

(45) Mention of the grant of the patent:
26.12.2012 Bulletin 2012/52

(21) Application number: 07836288.6

(22) Date of filing: 27.07.2007
(51) International Patent Classification (IPC): 
A61K 38/28(2006.01)
 A61K 9/00(2006.01)
(86) International application number:
PCT/US2007/016903
(87) International publication number:
WO 2008/013938 (31.01.2008 Gazette 2008/05)

(54)

AEROSOLIZABLE FORMULATION COMPRISING INSULIN FOR PULMONARY DELIVERY

SPRÜHBARE FORMULIERUNG MIT INSULIN ZUR PULMONALEN VERABREICHUNG

FORMULATIONS DE DÉRIVÉS D'INSULINE POUR ADMINISTRATION PULMONAIRE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 27.07.2006 US 833731 P

(43) Date of publication of application:
08.07.2009 Bulletin 2009/28

(73) Proprietor: Nektar Therapeutics
Wilmington, Delaware 19801 (US)

(72) Inventors:
  • KUO, Mei-Chang
    Palo Alto, California 94301 (US)
  • ELDON, Michael Alex
    Redwood City, California 94062 (US)
  • YUAN, YiQiong
    Alameda, California 94501 (US)

(74) Representative: Baldock, Sharon Claire et al
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)


(56) References cited: : 
WO-A-02/078675
WO-A-2008/013955
 WO-A-2005/067898
   
  • "INSULIN INHALATION - PFIZER/NEKTAR THERAPEUTICS" DRUGS IN R & D, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 5, no. 3, 2004, pages 166-170, XP008066361 ISSN: 1174-5886
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).